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Edited by Maurice MontalAbstract The pore-forming subunit of the large-conductance
Ca2+-dependent K+ (Slo1) channel is encoded by one gene. How-
ever, the functional properties of Slo1 channels are diverse in
part because of their numerous regulatory mechanisms including
posttranslational modiﬁcation and alternative splicing. In partic-
ular, multiple splice variants of the pore-forming subunit have
been reported but their signiﬁcance is only beginning to be eluci-
dated. Here we examined the cell biological properties of the
three common C-terminal isoforms that diﬀer in the last 8
(Slo1_ERL and Slo1_VYR) or 61 residues (Slo1_DEC). We
found that Slo1_DEC, the longest isoform, shows dramatically
reduced surface expression compared to that of Slo1_ERL or
Slo1_VYR. Immunocytochemistry revealed that a large fraction
of Slo1_DEC remains localized in endoplasmic reticulum (ER).
Using a GST fusion protein containing the Slo1_DEC-speciﬁc
sequence, aﬃnity puriﬁcation was carried out to isolate interact-
ing proteins. The identiﬁed proteins include protein phosphatase
2A (PP2A-A), actin, and tubulin. The PP2A-A interaction is
speciﬁc to Slo1_DEC and causes a signiﬁcant reduction of phos-
phorylation in Slo1_DEC but not Slo1_ERL or Slo1_VYR. The
results together support the notion that Slo1_DEC nucleates iso-
form-speciﬁc protein complexes and possesses a cis element(s)
for regulating traﬃcking of the Slo1 channels.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Large-conductance Ca2+-dependent K+ channels (also
known as Slo1, Maxi-K, BK and KCa1.1 channels), a member
of the voltage-gated K+ channel superfamily [1,2], are acti-
vated by membrane depolarization and elevated intracellular
[Ca2+] in an allosteric manner [3,4]. This dualistic activation
of BK channels is exempliﬁed in vascular smooth muscle cells
[5] and also in neurons [6] where the channels open to hyper-*Corresponding authors. Fax: +1 410 614 1001.
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doi:10.1016/j.febslet.2007.01.077polarize the cell membrane in response to a local increase in
intracellular [Ca2+], thus providing a negative feedback inﬂu-
ence on cellular excitability.
Functional properties of native Slo1/BK channels are di-
verse, such that their properties in diﬀerent tissues or even
neighboring cells may be markedly diﬀerent [7–14]. This
remarkable functional diversity arises by multiple molecular
mechanisms, including association with auxiliary subunits
and posttranslation modiﬁcation, such as phosphorylation,
and extensive alternative splicing [15,16]. The enzymatic mod-
iﬁcations of Slo1/BK channel, including those by phosphoryla-
tion, are particularly prominent [17,18], but the speciﬁc motifs
to anchor enzymatic assembly are largely unknown.
A functional Slo1 channel is composed of four pore-forming
subunits each of which is encoded by a single gene (KCNMA1)
[19,20]. The gene produces Slo1 proteins with seven putative
transmembrane segments, S0–S6, in addition to a large C-ter-
minal cytoplasmic domain with divalent cation binding sites
[21]. The C-terminus is in turn considered to contain two mod-
ules important for the channel gating, RCK1 (regulator of
conductance for K+) and RCK2 [22]. Within this topological
organization of Slo1, several alternative splicing sites have
been reported [13,15,16]. A splice insertion in the cytoplasmic
S0–S1 linker segment, referred to as SV1 (or n1 [13]), inﬂu-
ences traﬃcking of the protein to the surface membrane
[23,24] and also some aspects of the channel gating [25]. The
potential interaction between the identiﬁed motif and cellular
proteins remains a subject of further investigation. The cyto-
plasmic C-terminal domain also contains multiple splice sites
that profoundly inﬂuence the gating properties of the channel
[15,26–28]. For example, insertion of a cysteine-rich sequence
(‘‘STREX’’) between RCK1 and RCK2 at the c2 site regulated
in part by stress hormones [28], alters the channel gating and
its modulation by phosphorylation [29]. In addition to the
splice sites in the core of the cytoplasmic region, the extreme
C-terminus of Slo1 also harbors a splice site (Fig. 1). The ami-
no-acid sequence diﬀerence at the C-terminus caused by splic-
ing at this site was apparent when the full length cDNAs for
mouse and human Slo1 were ﬁrst reported [15,16,30,31]. How-
ever, the functional signiﬁcance of diﬀerent C-termini as a
result of this alternative splicing remains unknown.
As a ﬁrst step toward elucidating the biological signiﬁcance
of splicing at the extreme C-terminus, we expressed three C-
terminal variants, Slo1_DEC, Slo1_ERL and Slo1_VYR
(Fig. 1), in heterologous expression systems and found thatblished by Elsevier B.V. All rights reserved.
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Fig. 1. Schematic diagram of three common isoforms diﬀering at the C-terminal sequences as indicated.
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proteomic analyses have yielded a list of candidate interacting
proteins, setting the stage for future investigations to the
hypothesis that these cis- and trans-elements confer the diﬀer-
ences in both traﬃcking and biophysical properties of these
splicing variants.2. Results
The three C-terminal splice variants diﬀer in the extreme ter-
minal residues, hence we termed Slo1_DEC, Slo1_ERL and
Slo1_VYR. The Slo1_DEC isoform is the longest with 61 res-
idues distinct from the other two isoforms. The Slo1_ERL and
Slo1_VYR isoforms have identical length but diﬀer at the last
eight residues (Fig. 1). As expected, these isoforms form elec-
trophysiologically functional channels activated by depolariza-
tion and Ca2+ (Fig. 2A) when heterologously expressed. To
determine the cell biological signiﬁcance of the C-terminal res-
idues, we measured their whole-cell macroscopic currents.
Peak currents were normalized to the cell capacitance to esti-A DEC ERL
Fig. 2. Diﬀerential functional expression of Slo1 isoforms. (A) Representativ
virtual absence of Ca2+ at 80, 120, 160, and 100 mV (top) and at 100 lM [C
relative current densities at 200 mV for the three isoforms expressed in HEK2
the virtual absence of Ca2+ as outlined in Section 4. n = 8–12. ANOVA P <mate the relative electrophysiological expression eﬃciencies
of the isoforms (Section 4). Furthermore, in each transfection
batch, the current densities of the Slo1_DEC and Slo1_VYR
are normalized to the average current density of the commonly
studied Slo1_ERL isoform. Fig. 2B compares the relative elec-
trophysiological expression levels measured at 24–26 h after
transfection at 200 mV where open probability is essentially
saturated. The recording solutions contained 0 Ca2+ to avoid
confounding with any diﬀerential Ca2+ sensitivity among the
isoforms. It is clear that transfection with the three isoform
DNAs produced markedly diﬀerent current densities.
To test whether the diﬀerential current density is caused by
actual diﬀerent levels of protein expression on the cell surface,
we fused myc-epitope to the N-termini of the three isoforms.
Such protein tags do not induce any detectable eﬀects on sur-
face traﬃcking [23,24]. The surface expression levels of the
fusion proteins were measured by live cell staining using
anti-myc antibody followed by ﬂow cytometry (Fig. 3A). Both
Slo1_ERL and Slo1_VYR showed considerably higher surface
ﬂuorescence signals than Slo1_DEC. Furthermore, immuno-
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Fig. 3. Diﬀerential surface expression of Slo1 isoforms. (A) Histogram of ﬂow cytometry analyses of myc-tagged Slo1 isoforms that were expressed
in COS7 cells (upper panels). Surface expression was quantiﬁed using geometric mean ﬂuorescence and plotted as relative surface expression levels
(lower panel). (B) Immunoprecipitation of Slo1 proteins on cell surface (upper panel) and in total cell lysates (lower panel). Indicated isoforms of
Slo1 channel proteins were immunopreciated by anti-myc antibody and blotted by anti-Slo1 antibody. (C) Immunoﬂuorescent imaging of cells
labeled with anti-myc antibody. COS7 cells were transfected with three myc-Slo1 isoforms. The transfected cells were labeled with anti-myc antibody
without detergent treatment (upper panels) or after detergent treatment (lower panels). (D) Confocal imaging of Slo1_DEC proteins. COS7 cells were
transfected with Slo1_DEC and stained with both mouse anti-myc antibody and rabbit anti-calreticulin antibody. The corresponding secondary
antibodies labeled with Alexa Fluor 488 (Slo1) or Alexa Fluor 568 (calreticulin) were then applied to visualize the primary antibodies. Their images
were then merged (right). (E) Surface expression of Slo1 heteromultimers formed by diﬀerent isoforms. Indicated combinations of CD4, myc-
Slo1_DEC, HA-Slo1_DEC, myc-Slo1_ERL and HA-Slo1_ERL constructs were transfected in COS7 cells. The surface expression for each
transfection was monitored by anti-myc antibody and quantiﬁed according to the geometric mean ﬂuorescence of ﬂow cytometry histograms.
1002 D. Ma et al. / FEBS Letters 581 (2007) 1000–1008were carried out to compare the relative surface expression of
the isoforms (Section 4). The surface protein levels for
Slo1_ERL and Slo1_VYR are more abundant than that of
Slo1_DEC, even though the total proteins of the three iso-
forms are comparable (Fig. 3B), indicative that the diﬀerential
surface expression was not caused by diﬀerence in total protein
production.
To directly visualize the subcellular localization of the three
isoforms, transfected COS7 cells were stained with anti-myc
antibody. Fig. 3C (upper panels) reveals signiﬁcant surface
signals for both the ERL and VYR isoforms but not the
DEC isoform. In contrast, when the cells were stained after
membrane permeabilization by detergent treatment, consider-
able antibody binding signals were found intracellularly for
Slo1_DEC (Fig. 3C, lower panel). Further analyses by double
stain with both anti-myc and anti-calreticulin revealed that
intracellularly localized Slo1_DEC overlapped noticeably withsignals of calreticulin, a well known ER protein (Fig. 3D),
providing the evidence that the Slo1_DEC is mainly localized
in ER.
Slo1_DEC forms functional homomeric channels (Fig. 2)
and there is evidence for overlapping expression of C-terminal
isoforms [32]. To determine the surface expression level upon
interaction with other isoforms, we coexpressed Slo1_DEC
with Slo1_ERL or control membrane protein CD4. Fig. 3E
summarizes the anti-myc staining intensities with diﬀerent
co-expression combinations. Indeed, co-expression of Slo1_
DEC with Slo1_ERL resulted in low surface expression similar
to that of Slo1_DEC alone, as measured by either the level of
myc-Slo1_DEC or myc-Slo1_ERL. This observation provides
the evidence that the isoforms are capable of interacting with
each other and that the C-terminal region speciﬁc for Slo1_
DEC isoform has dominant suppressive activity on channel
surface expression.
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Fig. 4. Deletion analyses of Slo1_DEC isoform. Individual deletions with indicated amino acid positions were constructed (left panel) and expressed
in COS7 cells. The indicated constructs were then tested for the surface expression using anti-myc antibody. Quadruplicate experiments were
performed and quantiﬁed according to the geometric mean ﬂuorescence of ﬂow cytometry histograms (right panel).
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the traﬃcking behavior, we constructed a series of Slo1_DEC
deletion mutants (Fig. 4, left panel). The surface expression of
these mutants was then measured by ﬂow cytometry. The geo-
metric mean ﬂuorescence was used to quantify the relative sur-
face expression (Fig. 4, right panel). Intriguingly, the
progressive deletion gradually increased the surface expression.
The complete removal of DEC-speciﬁc region, spanning from
aa 1109 to 1169, allowed for a complete recovery of surface
expression to a level similar to that of Slo1_ERL or Slo1_VYR
(Fig. 4, right panel).
Slo1_DEC isoform may diﬀer in other aspects in addition to
lower surface expression, we constructed a GST-DEC fusion
protein spanning from aa1056 to aa1169 (GST-DEC1056/
1169). This covers the entire Slo1_DEC-speciﬁc region and a
fragment of upstream sequence shared among the three iso-
forms. Using aﬃnity puriﬁcation, brain proteins speciﬁc for
GST-DEC1056/1169 but not GST alone have been puriﬁed
(Fig. 5A). Several candidate interacting proteins have been
identiﬁed by matrix-assisted laser desorption/ionization-time
of ﬂight mass spectrometry (MALDI-TOF MS) (see Section
4; Table 1).
The positively identiﬁed proteins included protein phospha-
tase 2A A subunit (PP2A-A), and cytoskeletal proteins (both
actin and tubulin). Table 2 lists all the digested peptides that
match the theoretical tryptic peptides calculated for the
PP2A-A. The estimated molecular weight of PP2A-A is
around 65.3 kDa. The core enzyme of the protein phosphatase
2A is a dimer, which consists of a 65 kDa structural subunit
and a 36 kDa catalytic subunit (PP2A-C). To biochemically
validate the mass spectral analysis and detect the existence of
the catalytic subunit, the eluates from both GST and GST-
DEC (1056–1169) aﬃnity columns were immunoblotted by
the anti-PP2A-A and anti-PP2A-C antibodies. From the
immunoblot analysis, it is clear that both PP2A-A and
PP2A-C subunits were only present in the eluate of GST-DEC (1056–1169) aﬃnity column, but absent in the eluate of
GST column (Fig. 5B and C). The preferential PP2A-A bind-
ing was further determined by coimmunoprecipitation experi-
ments using full length Slo1 a-subunit. Fig. 5D shows
immunoblots of anti-myc precipitates probed with antibodies
for PP2A-A or PP2A-C subunits. While the precipitated Slo1
isoforms were comparable, PP2A-A signal was considerably
stronger in the Slo1_DEC lane. To test for any eﬀect of
PP2A association on the Slo1 channel proteins, we expressed
GST-fusion proteins for all three isoforms in COS7 cells and
performed metabolic labeling using [32P]-orthophosphate.
The 32P level of the GST-DEC fusion protein is remarkably
lower than the other two GST fusion proteins, GST-ERL
and GST-VYR (Fig. 5F). This ﬁnding is well correlated with
PP2A-A binding (Fig. 5E). Together, these results support
the notion that the C-terminal domain of Slo1_DEC is capable
of recruiting a large protein complex with posttranslational
enzymatic activities.3. Discussion
The diﬀerence in primary sequence at the extreme C-termi-
nus for cloned Slo1 channels was immediately noticed after
the initial cloning. In this report, we have provided evidence
that Slo1_DEC, the longest form, displays considerably lower
but functional surface expression. Further investigation
showed that a large fraction, but not all, of the Slo1_DEC iso-
form is localized in ER, consistent with the idea that this iso-
form has an ER localization activity or confer an overall
reduction in forward transport activity. Furthermore, the
strong ER localization behavior of the Slo1_DEC isoform is
‘‘dominant’’ when it is co-assembled with the normally high-
expressing Slo1_ERL isoform.
The mechanism by the DEC-speciﬁc amino-acid residues at
the extreme C-terminus promotes retention of the channel in
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Fig. 5. Proteins interacting with the C-terminal domain of Slo1_DEC. (A) Commassie stain image of aﬃnity-puriﬁed proteins interacting with GST-
DEC 1056/1169 fusion. Indicated proteins are positively identiﬁed by MALDI-TOF analyses (Table 1). (B and C) Aﬃnity pull-down proteins by
either GST or GST-DEC 1056/1169 were immunobloted with anti-PP2A-A (B) or anti-PP2A-C antibodies (C). (D) Immunoprecipitation of full-
length myc-Slo1 isoforms. The immunoprecipitated materials were probed with anti-PP2A-A (upper), anti-PP2A-C (middle) and anti-myc (lower)
antibodies. (E and F). Metabolic labeling of GST fusion proteins expressed in COS7 cells. The indicated GST fusion proteins were expressed in COS7
cells and metabolically labeled with 32P orthophosphate (Section 4). The GST fusion proteins were precipitated by glutathione–Sepharose and
fractionated by SDS–PAGE. Bound materials were probed with anti-PP2A-A (E, upper panel) and the input protein lysates of transfected cells were
probed with anti-PP2A-A antibody (E, lower panel). The metabolically labeled GST proteins in each transfection were monitored by
autoradiography after eluted from the glutathione–Sepharose (F). Diﬀerent fusion constructs are shown on the top of each panel. Molecular weight
standards in kDa are as indicated. All experiments have been replicated at least three times.
1004 D. Ma et al. / FEBS Letters 581 (2007) 1000–1008ER is not entirely clear. However, our deletion analysis sug-
gests that the ER retention propensity is approximately pro-
portional to the number of the DEC-speciﬁc residues present
at the C-terminus in an apparently graded manner. As few
as 10 DEC-speciﬁc residues at the C-terminus can appreciably
interfere with surface expression (Fig. 4), consistent with a
high degree of sequence speciﬁcity. ER localization signals
are typically small peptide motifs interacting with COPI com-
plex [33,34]. Intriguingly, our deletion analyses instead suggestthe DEC-speciﬁc residues serve the ER localization in an
apparently graded manner (Fig. 4). One possibility causing
the DEC-speciﬁc behavior is the formation of a unique protein
complex. The potential causal eﬀect by assembled enzymes re-
quires thorough investigation.
The DEC C-terminus is capable of intimately interacting
with actin, tubulin, and PP2A-A, as revealed by our aﬃnity
puriﬁcation and proteomics analyses. The DEC C-terminus
thus acts to nucleate this large protein complex involving mul-
Table 2
PP2A-A peptides identiﬁed from the MALDI-TOF mass spectrometry
Measured mass Matching mass DMass (ppm) Position Missed cleavage Peptide
873.4056 873.4430 43 22–28 0 NEDVQLR
929.4519 929.5308 85 195–202 0 VLELDNVK
1109.4708 1109.5380 61 135–144 0 LAGGDWFTSR
1160.5555 1160.5799 21 567–576 0 LTQDQDVDVK
1165.5657 1165.6370 61 476–485 0 EWAHATIIPK
1242.6527 1242.7422 72 35–46 0 LSTIALALGVER
1376.6373 1376.7248 64 281–292 0 TDLVPAFQNLMK
1472.6996 1472.7320 22 486–498 0 VLAMSGDPNYLHR
1472.6996 1472.7459 31 261–272 0 YMVADKFTELQK
2137.9544 2138.0076 25 203–221 0 SEIIPMFSNLASDEQDSVR
2194.1911 2194.2335 19 547–566 0 IGPILDNSTLQSEVKPILEK
2213.0960 2213.1355 18 114–133 0 AISHEHSPSDLEAHFVPLVK
Table 1
Proteomic identiﬁcation of Slo1_DEC associated proteins
Protein identiﬁed Accession number Molecular mass (kDa) MALDI-TOF MS
Matching peptides Protein coverage (%)
CK2a Q60737 45.162 16 45
CK2a 0 O54833 41.216 8 24
PP2A-A subunit AAH52678 65.267 18 30
Tubulin, a1 AAH83344 50.120 15 28
c-actin CAA31455 40.992 17 30
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PP2A with Slo1_DEC raises the intriguing possibility that
the enzymatic activity in one subunit in a tetrameric channel
may regulate its own state of phosphorlylation as well as those
of the neighboring subunits. This intra- and inter-subunit reg-
ulation may then contribute to the isoform speciﬁcity including
the channel surface expression. Phosphorylation-dependent
surface expression of proteins represents a new emerging con-
cept in the cell biology of ion channel regulation. Recent exam-
ples include activity-dependent surface expression mediated by
14-3-3 [35]. Whether PP2A-mediated reduction of phosphory-
lation causes the lower surface expression of the Slo1_DEC is
an interesting subject of future investigation.
While the overall expression level is low, some Slo1_DEC
channels along with the interacting protein partners are in-
deed found in the plasma membrane as a macromolecular sig-
naling complex. Indeed, Slo1 channels function as a large
macromolecular complex [36]. Functional interactions with
nucleotide-dependent protein kinase and phosphatase activi-
ties have been reported and that the enzymatic activities reg-
ulate functional properties of the channel complex allows
local and spatially directed intracellular signaling [17,18].
Thus, functional properties of a Slo1_DEC complex, such as
the allosteric voltage- and Ca2+-dependent gating [37], may
be regulated by PP2A present within the same complex.
Whether the Slo1_DEC channel complex is regulated by
PP2A in concert with other reported kinase activities waits
further investigation. Their identity and validation of interac-
tions are under way. The puriﬁed actin and tubulin are consis-
tent with the recent reports [38–40]. Accumulating evidence
indicates that Slo1 channel macromolecular complexes may
involve not only enzymes and cytoskeletal elements but also
other ion channel and receptor proteins [6,41]. Thus, that
enzymatic components in the DEC isoform inﬂuence theneighboring channels or receptors within one macromolecular
complex is an interesting possibility.
In summary, our results demonstrate that the Slo1 channel
variants produced by alternative splicing diﬀering in the
extreme C-terminal sequence show diﬀerent traﬃcking proper-
ties. Furthermore, the Slo1 channel variants form distinct
macromolecular signaling complexes with diﬀerent phosphory-
lation and dephosphorylation capabilities, uncovering addi-
tional layers of modulatory potential and diversity of Slo1
channels. Alternative splicing of the Slo1 channel pre-mRNA
is plastic and regulated by speciﬁc hormone stimulation or dur-
ing diﬀerent stages of pregnancy [28,42,43]. Thus, it would be
interesting to see if the splicing at the C-terminus is subject to
regulation in vivo.4. Experimental
4.1. Plasmid construction
Slo1_DEC, which is the mbr5 clone of mouse brain mslo1 [15], was
obtained from Dr. Jianmin Cui (Washington University, St Louis,
MO). The other two isoforms, Slo1_ERL and Slo1_VYR, were con-
structed by PCR ampliﬁcation and mutagenesis using mbr5 clone as
a template. For expression of full-length Slo1 channel protein or their
partial C-terminal fragments in mammalian cells, the inserts were
cloned at SalI and NotI sites into cytomegalovirus (CMV) pro-
moter-based expression vectors with N-terminal tag of myc, HA,
and GST. For bacterial GST fusion proteins, pGEX4T2 vector (GE
Healthcare, Piscataway, NJ) was used to clone Slo1 inserts at SalI
and NotI.
4.2. Cell culture and transfection
COS7 and HEK293 cells were cultured in 50%DMEM/50%F12
medium supplemented with 10% fetal bovine serum, L-glutamine and
penicillin–streptomycin. The plasmid DNA was transfected using Fu-
Gene6 (Roche, Indianapolis, IN) according to the manufacturer’s
instruction.
1006 D. Ma et al. / FEBS Letters 581 (2007) 1000–10084.3. Flow cytometry and quantiﬁcation of surface expression level of Slo1
channel
COS7 cells cultured in 6-well plates were transfected with 1 lg of
plasmids. At 36 h after transfection, the cells were harvested by incuba-
tion in phosphate-buﬀered saline (PBS, pH 7.3) containing 0.5 mM
ethylenediaminetetraacetic acid (EDTA) for 10 min at 37 C. After
washing with Hanks’ balanced salt solution (HBSS) supplemented
with 2% FBS (staining medium), the cells were incubated with mouse
anti-myc monoclonal antibody (Santa Cruz Biotechnology, Santa
Cruz, CA) at 5 lg/ml in staining medium for 30 min on ice. After
washing three times, the cells were incubated for 10 min with Alexa
Fluor 488-conjugated goat anti-mouse antibody (Invitrogen, Carlsbad,
CA). After washing the cells three times, the surface expression of Slo1
channel proteins was measured by FACSCalibur (BD Biosciences,
Rockville, MD) with CELLQUEST software (BD Biosciences).
4.4. Immunocytochemistry for Slo1 channel localization
COS-7 cells transfected with Slo1 constructs were cultured on cover
slips for 24 h. To ﬁrst stain the surface-localized Slo1 channel proteins,
the cells were incubated with anti-myc antibody for 1 h at 4 C. After
wash, the cells were ﬁxed with 4% paraformaldehyde for 15 min at 4 C
and then permeabilized with 0.1% Triton X-100 for 5 min. The perme-
abilized cells were labeled with rabbit polyclonal anti-myc antibody
(Santa Cruz Biotechnology) for 1 h at 4 C, followed by labeling with
Alexa Fluor 488-goat anti-mouse antibody and Cy3-conjugated goat
anti-rabbit antibody (Jackson ImmunoResearch Laboratories, West
Grove, PA) for 30 min to detect surface and intracellular Slo1 proteins,
respectively. The Slo1_DEC protein was further examined for subcel-
lular localization. The transfected COS7 cells were ﬁxed and permeabi-
lized as described above. The cells were stained with both mouse
anti-myc antibody and rabbit anti-calreticulin (Aﬃnity Bioreagent,
Golden, CO) and then with corresponding secondary antibodies con-
jugated with Alexa Fluor 488 (Slo1) or Alexa Fluor 568 (calreticulin).
The staining signal was visualized with Ultraview confocal microscope
(Carl Zeiss, Thornwood, NY).
4.5. In vivo phosphorylation assay of Slo1 C-terminal proteins
HEK293 cells transfected with GST fusion constructs were re-plated
on 6-well plates 1 day after the transfection. On the following day,
after incubation in serum- and phosphate-free medium for 1 h, the cells
were labeled with 0.3 mCi/ml of [32P]-orthophosphate (ICN Biomedi-
cals, Irvine, CA) for 2 h. The cells were then lysed in cell lysis buﬀer
(1% Triton X-100, 25 mM HEPES, pH 7.5, 10% glycerol, 50 mM
KCl, and 1· protease inhibitor cocktail (Sigma, St. Louis, MO)) and
the GST fusion proteins were pulled down by the glutathione–Sephar-
ose beads. The pull-down protein samples were fractionated by
SDS–polyacrylamide gel electrophoresis (PAGE) and transferred to
a nitrocellulose membrane. The phosphorylated proteins were then
detected by phospho-imaging analysis. The association of PP2A core
enzyme was detected by immunoblotting using goat polyclonal anti-
PP2A-A (Santa Cruz Biotechnology) and mouse monoclonal anti-
PP2A-C (BD Biosciences) followed by corresponding secondary
antibodies supplied with SuperSignal chemiluminescence reagent
(Pierce Chemical, Rockford, IL).
The amount of pull-down GST fusion proteins was determined by
Ponceau S staining or immunoblotting with horse radish peroxidase
(HRP)-conjugated anti-GST polyclonal antibody (GE Healthcare, Pis-
cataway, NJ).4.6. Immunoprecipitation of myc-tagged Slo1 proteins
The cells transfected with full-length myc-Slo1 constructs were
washed with PBS once and lysed with lysis buﬀer for 20 min at 4 C.
After centrifuge for 20 min at 11000 · g, the supernatant was mixed
with Protein G-conjugated agarose beads which were pre-incubated
with 1 lg of anti-myc antibody. After 2 h incubation, the beads were
washed three times with lysis buﬀer, boiled with 2· SDS sample buﬀer
for 5 min. The eluates were resolved by SDS–PAGE, transferred to the
nitrocellulose membrane, and then immunoblotted by rabbit poly-
clonal anti-Slo1 antibody (Alomone Labs, Jerusalem, Israel) or anti-
PP2A antibodies followed by corresponding secondary antibodies as
described for GST fusion proteins.
For immunoprecipitation of cell surface Slo1 proteins, the transfec-
ted cells were ﬁrst labeled with anti-myc antibody for 1 h at 4 C. After
extensive wash with staining medium, the cells were lysed with lysisbuﬀer and then the centrifuged supernatant was incubated with Protein
G beads for 2 h. After wash, the eluates were resolved by SDS–PAGE
and immunoblotted with anti-Slo1 antibody. In the parallel experi-
ments, the cell lysates were made from myc-Slo1-transfected cells
and the centrifuge supernatants were immunoprecipitated to quantify
total Slo1 channel proteins.4.7. Puriﬁcation of bacterial GST-fused Slo1 proteins
The BL21 E. coli carrying GST or GST fusion constructs were
induced for protein expression by isopropylthiogalactoside (IPTG).
The bacterial cells were sonicated in PBS on ice, and then incubated
in 1% Triton X-100 for 30 min. The lysate was centrifuged at
15000 · g for 20 min at 4 C and the supernatant was incubated with
glutathione–Sepharose for 30 min. After washing three times with
PBS, the beads were resuspended as 50% slurry in PBS.4.8. Aﬃnity puriﬁcation of Slo1_DEC channel C-terminus-associated
proteins
Four grams of mouse brains were homogenized on ice with a glass
homogenizer in 10 ml of Buﬀer A (20 mM HEPES–KOH (pH 7.5),
25 mM KCl, 1 · protease inhibitor cocktail, 0.5 mM dithiothreitol,
10% sucrose). The homogenate was centrifuged at 500 · g for 10 min
at 4 C and the supernatant was mixed with equal volume of solubili-
zation buﬀer (Buﬀer A added with 4 M NaCl) for 1 h at 4 C to extract
any soluble proteins. After centrifuge at 27000 · g for 15 min at 4 C
to remove insoluble matters. The supernatant was dialyzed against
buﬀer A without sucrose for three times overnight and then centrifuged
at 27000 · g for 20 min to remove any insoluble matters. The superna-
tant was pre-cleared twice with glutathione–Sepharose resin to remove
any non-speciﬁc binding proteins. The pre-cleared mouse brain lysate
samples (equivalent of 20 mg proteins) were subjected to aﬃnity puri-
ﬁcation with control GST or GST-fused Slo1 proteins that were bound
to glutathione–Sepharose. After incubation with brain samples for 2 h
at 4 C, the resins were washed extensively with buﬀer A. The associ-
ated proteins were eluted with 500 mM NaCl in buﬀer A. The eluates
were resolved by SDS–PAGE and visualized by Commassie Brilliant
Blue (CBB) staining.4.9. Protein identiﬁcation by MALDI-TOF mass spectrometry
Proteins of interest were excised from CBB-stained gels and di-
gested in gel using trypsin (sequencing grade, Promega, Madison,
WI), as previously described [44]. Digest products were completely
dehydrated in a vacuum centrifuge and resuspended in 10 ll formic
acid (2% v/v), desalted using Zip Tips C18 (Millipore, Bedford,
MA), eluted with 2 ll acetonitrile:triﬂuoroacetic acid, (80:0.1%). The
extracted peptides were mixed with the 2,5-dihydroxybenozic acid
(10 mg/ml in acetonitrile:triﬂuoroacetic acid, 50:0.1%) and loaded on
the sample plate of the MALDI-TOF mass spectrometer. Analysis
was performed on the Voyager DE-STR MALDI-TOF in the Johns
Hopkins protein core facility. Mass spectra were acquired as the
sum of the ion signals that were generated by irradiation of the sam-
ple with a mean of 300 laser pulses. Spectra were analyzed using the
Data Explorer software (Applied Biosystems, Foster City, CA).
Peptides were selected in the mass range of 800–3500 Da. Identiﬁca-
tion of proteins was performed by using Mascot software (Matrix
Science Inc, Boston, MA). A mass deviation of 100 ppm was allowed
for data base interrogation.4.10. Electrophysiology
The three isoforms were transiently expressed in HEK293 cells as
described previously [45] and the whole-cell currents were recorded
at 24–26 h later with an AxoPatch 200B ampliﬁer (Molecular Devices,
Sunnyvale, CA). The extracellular solution contained (in mM): 20
KCl, 120 N-methyl-D-glucamine (NMDG), 2 MgCl2, 10 HEPES,
pH 7.2. The intracellular (pipette) solution contained (in mM): 20
KCl, 120 NMDG, 2 MgCl2, 11 EGTA, 10 HEPES, pH 7.2. The K
+
concentration was lowered to 20 mM to limit the peak current size.
Cell capacitance was estimated using 25 mV depolarization pulses. In-
side-out macroscopic currents were recorded with diﬀerent size elec-
trodes to obtain <20 nA currents at 200 mV. The solutions used in
the inside-out experiments contained 140 KCl replacing 20 KCl and
120 NMDG. The 100 lM Ca2+ results were obtained using a solution
D. Ma et al. / FEBS Letters 581 (2007) 1000–1008 1007without any chelator. The results obtained in the virtual absence of
Ca2+ were corrected for capacitative and leak currents using a P/6 pro-
tocol and the high Ca2+ results were not corrected for leak or capaci-
tative currents.
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